LogicBio Therapeutics Reports First Quarter Year 2021 Financial Results and Provides Business Update

Author's Avatar
May 10, 2021

- First patient for Phase 1/2 SUNRISE trial expected to be enrolled by mid-year 2021

- Business Development Deals signed with Daichi-Sankyo and CANbridge Pharmaceuticals

- New members recently added to Leadership Team

PR Newswire